Dave Elmore
About Dave Elmore
Dave Elmore is an Associate Cryo Nerve Block Territory Manager at AtriCure, Inc., with extensive experience in sales management within the medical device and biotechnology sectors. He has held various sales roles at companies such as Optos, Radius Health, and Amgen, and has been recognized for his leadership in sales and exceptional performance.
Current Role at AtriCure
Dave Elmore serves as the Associate Cryo Nerve Block Territory Manager at AtriCure, Inc. since 2023. In this role, he is responsible for managing sales and promoting cryo nerve block technologies in the Buffalo, New York area. His focus is on expanding the market reach of AtriCure's innovative medical solutions.
Previous Experience in Medical Sales
Prior to his current position, Dave Elmore held various roles in medical sales. He worked at Optos as an Account Manager from 2018 to 2023, covering regions in Upstate New York, Vermont, and parts of Pennsylvania. He also served as a Clinical Sales Specialist at Radius Health, Inc. from 2017 to 2018, and as an Otology Clinical Sales Specialist at Otonomy, Inc. from 2016 to 2017.
Educational Background
Dave Elmore studied Biology at Buffalo State University, where he earned a Bachelor of Arts degree. He also attended the College of Charleston, furthering his education in the same field. His academic background provides a solid foundation for his career in medical sales.
Sales Leadership and Achievements
Dave Elmore has been recognized as a leader in sales, particularly in the field of disruptive technology. He has extensive experience in sales management and reimbursement within the medical device and biotechnology sectors. His performance has been acknowledged through achievements such as attaining President's Club status, which reflects exceptional sales performance.
Comprehensive Sales Expertise
With a strong skill set in consulting for medical devices, biotechnology, and capital equipment, Dave Elmore brings extensive knowledge to his roles. His background includes working with various companies, such as Alimera Sciences and Amgen, where he developed expertise in specialty biopharmaceuticals and clinical sales.